BELIMUMAB, A BLYS-SPECIFIC INHIBITOR, REDUCES DISEASE ACTIVITY AND SEVERE FLARES IN SEROPOSITIVE SLE PATIENTS: BLISS-76 STUDYR. van Vollenhoven,O. Zamani,D. Wallace,D. Tegzova,J. Merrill,W. Chatham,A. Schwarting,F. Hiepe,A. Doria, J. Sanchez-Guerrero,S. Jeka, A. Dyczek,R. Furie, M. Petri,D. D'Cruz, Z. Fojtik,L. Pineda,Z. Zhong,D. Hough,W. Freimuth,R. CerveraClinical and Experimental Rheumatology（2011）引用 24|浏览19暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
